Sublingual immunotherapy vs control
All adverse events Weighted mean duration of studies: 60 weeks** · people with asthma
Sublingual immunotherapy leads to higher all adverse events Weighted mean duration of studies: 62 weeks** compared with control (high certainty).
1 finding from 1 review
- OR 1.99 [1.49, 2.67]27 studies · 4251 participantsHigh